Physician profile
Julia Harris
NPI 1750315107
$9,121.96
in general payments reported to CMS, 2019-2025
34 companies · $574 in 2025
The $574 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,242 · 2020: $1,726 · 2021: $1,824 · 2022: $1,064 · 2023: $917 · 2024: $775 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,266.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,683.84 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,062.91 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Glaxosmithkline, LLC. | $634.66 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $630.45 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $554.93 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $554.59 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Kowa Pharmaceuticals America, INC. | $529.14 | 2019-2025 | Zoryve, Livalo |
| Janssen Pharmaceuticals, INC | $473.61 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $383.05 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Currax Pharmaceuticals LLC | $377.37 | 2020-2022 | |
| Merz North America, INC. | $331.47 | 2019-2021 | |
| Amgen INC. | $248.14 | 2019-2024 | Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $229.80 | 2020-2023 | |
| Astellas Pharma US INC | $194.89 | 2019-2025 | Veozah |
| Amarin Pharma, INC. | $171.23 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $143.19 | 2023 | Nuvent |
| Allergan, INC. | $117.50 | 2019-2022 | |
| Abbvie INC. | $114.86 | 2021-2024 | |
| Bard Peripheral Vascular, INC. | $94.08 | 2020 | |
| Abbott Laboratories | $91.48 | 2021-2023 | Freestyle Libre 2 |
| Esperion Therapeutics, INC. | $85.07 | 2020-2025 | Nexletol |
| Eisai INC. | $64.35 | 2022-2024 | |
| Idorsia Pharmaceuticals US INC | $61.50 | 2022-2023 | Quviviq |
| Boston Scientific Corporation | $59.44 | 2023 | Watchman Access System |
| Ibsa Pharma INC. | $48.12 | 2020 | |
| Vivus LLC | $30.32 | 2019-2020 | |
| Inspire Medical Systems, INC. | $24.62 | 2025 | Inspire |
| Exact Sciences Corporation | $23.52 | 2025 | The Cologuard Plus Collection Kit |
| Nevro Corp. | $20.05 | 2023 | Senza |
| Therapeuticsmd, INC. | $18.99 | 2019 | |
| Corcept Therapeutics | $18.88 | 2025 | Korlym |
| Sanofi Pasteur INC. | $17.17 | 2023 | |
| Almatica Pharma LLC | $15.79 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.